Get the Stockscreener App
5.215
4.92%
0.235
Oncology Institute Inc stock is traded at $5.215, with a volume of 167.86K.
It is up +4.92% in the last 24 hours and down -3.06% over the past month.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
See More
Previous Close:
$4.98
Open:
$5.03
24h Volume:
167.86K
Relative Volume:
0.09
Market Cap:
$521.91M
Revenue:
$545.76M
Net Income/Loss:
$-36.28M
P/E Ratio:
-13.89
EPS:
-0.3754
Net Cash Flow:
$-25.73M
1W Performance:
-5.00%
1M Performance:
-3.06%
6M Performance:
+70.75%
1Y Performance:
+41.98%
1-Day Range:
$5.03
$5.32
1-Week Range:
$4.9612
$5.5926
52-Week Range:
$2.32
$6.67
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
5.22 | 497.92M | 545.76M | -36.28M | -25.73M | -0.3754 |
HCA
Hca Healthcare Inc
|
389.60 | 84.78B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
244.57 | 20.09B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
238.11 | 15.11B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.93 | 13.21B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
113.90 | 11.20B | 6.07B | 793.80M | 464.40M | 5.9914 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Initiated | Needham | Buy |
| Jul-23-25 | Initiated | Noble Capital Markets | Outperform |
| Jul-16-25 | Initiated | B. Riley Securities | Buy |
| May-15-25 | Initiated | BTIG Research | Buy |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
View All
Oncology Institute Inc Stock (TOI) Latest News
Oncology Institute Inc (TOI) Income Statement - TradingKey
Oncology Institute Inc (TOI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Oncology Institute Inc (TOI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
The Oncology Institute Inc. (TOI) Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline, Revenue Uncertainty Caps StockCFO Commentary Report - dars.gov.et
Insider Buying: Jorey Chernett Acquires Additional Shares of The Oncology Institute Inc (TOI) - GuruFocus
The Oncology Institute (TOI) Sheds Nearly 2% Amidst Sector Headwinds, Support TestedLeading Diagonal - dars.gov.et
Oncology Institute, Inc. (TOI) 10% owner adds 18,000 shares in open-market buy - Stock Titan
Oncology Institute CMO Yale Podnos disposes of 23,452 common shares worth $150,362.95 - Bitget
Oncology institute CMO Yale Podnos sells $150k in shares By Investing.com - Investing.com South Africa
Form 4 Oncology Institute Inc For: 16 July By Investing.com - Investing.com Nigeria
Oncology Institute, Inc. (TOI) CMO sells 23,452 shares after option exercises - Stock Titan
Oncology institute CMO Yale Podnos sells $150k in shares - Investing.com
Is Oncology Institute (TOI) One of the Best Future Stocks to Buy Under $10? - Yahoo Finance
The Oncology Institute Warrant (TOIIW) Stalls at $0.07 as Trading Remains FlatETF Creation Redemption - dars.gov.et
Form 144 The Oncology Institute For: 14 July By Investing.com - Investing.com Nigeria
TOI (NASDAQ: TOI) plans sale of 23,452 shares worth $146,575.00 - Stock Titan
Form 4 Oncology Institute Inc For: 13 July By Investing.com - Investing.com Australia
Oncology institute: 10% owner Jorey Chernett buys $87,750 stock - Investing.com UK
Oncology institute: 10% owner Jorey Chernett buys $87,750 stock By Investing.com - Investing.com Nigeria
Oncology Institute (TOI) major holder buys 15,000 shares in open market - Stock Titan
DFPH SEC FilingsOncology Institute, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
The Oncology Institute (TOI) Proxy filing Summary - Quartr
TOIIW SEC FilingsThe Oncology Institute Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Oncology Institute (TOI) Short Interest & Short Float | Updated Jul 2026 $TOI - MarketBeat
Oncology Institute Price Target Raised to $9.00/Share From $8.00 by BTIG - Moomoo
Oncology Institute (TOI) director receives 17,185-share fully vested RSU grant - Stock Titan
Oncology Institute (TOI) director receives 25,833 fully vested RSU shares - Stock Titan
TOI Maintained by BTIG -- Price Target Raised to $9.00 - GuruFocus
BTIG raises Oncology Institute stock price target to $9 on debt refinancing By Investing.com - Investing.com South Africa
BTIG raises Oncology Institute stock price target to $9 on debt refinancing - Investing.com Nigeria
BTIG Maintains The Oncology Institute(TOI.US) With Buy Rating, Raises Target Price to $9 - Moomoo
Oncology Institute Refinances Debt with New Term Loan - TipRanks
Oncology Institute (NASDAQ: TOI) adds $75M OrbiMed loan in major refi - Stock Titan
Needham Maintains The Oncology Institute(TOI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Oncology Institute refinances $86m debt with OrbiMed By Investing.com - Investing.com Nigeria
Enterprise value to revenue forward of The Oncology Institute, Inc. – NASDAQ:TOI - TradingView
Oncology Institute refinances $86m debt with OrbiMed - Investing.com
The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity - The Manila Times
The Oncology Institute Refinances $86 Million Debt Through OrbiMed Agreement - geneonline.com
Press Release: The Oncology Institute Completes Strategic Refinancing With OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening Its Balance Sheet, and Improving Liquidity - 富途牛牛
TOI Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Market ResponseCapex Guidance - dars.gov.et
Lake Street Initiates The Oncology Institute(TOI.US) With Buy Rating, Announces Target Price $10 - Moomoo
Why Oncology Institute’s (TOI) Analyst Upgrades Put Its Community Cancer Care Growth Story in Focus - Insider Monkey
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.83%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):